Long-term exposure to ambient air pollution and the incidence of nonalcoholic fatty liver disease: a cohort study
- PMID: 40574482
- PMCID: PMC12202766
- DOI: 10.1093/ije/dyaf101
Long-term exposure to ambient air pollution and the incidence of nonalcoholic fatty liver disease: a cohort study
Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) affects approximately one-third of adults and may progress to advanced fibrosis and hepatocellular carcinoma. Epidemiologic studies linking air pollution to NAFLD incidence remain limited. This study examined associations between long-term exposure to ambient air pollution and NAFLD incidence.
Methods: The study included 62 660 adults in Taiwan undergoing health examinations from 1996 to 2016. NAFLD was diagnosed through liver ultrasonography; individual characteristics and medical history were obtained from questionnaires. Residential township data estimated exposure to fine particulate matter (PM2.5), nitrogen dioxide (NO2), and carbon monoxide (CO). Time-dependent Cox regression was conducted to assess associations between air pollution and NAFLD incidence.
Results: The overall NAFLD incidence was 53.0 cases per 1000 person-years. Adjusted models showed positive associations between air pollutants and NAFLD. Compared with low exposure to both PM2.5 and NO2, the adjusted hazard ratio (HR) [95% confidence interval (CI)] for high exposure to both was 1.25 (1.19-1.31). Similarly, compared with low exposure to both PM2.5 and CO, the adjusted HR (95% CI) was 1.12 (1.07-1.17) for low PM2.5 and high CO, and 1.28 (1.22-1.33) for high exposure to both.
Conclusion: Long-term exposure to PM2.5 and traffic-related air pollutants, including NO2 and CO, may increase the risk of developing NAFLD.
Keywords: air pollution; nonalcoholic fatty liver disease; particulate matter; traffic-related air pollutant.
© The Author(s) 2025. Published by Oxford University Press on behalf of the International Epidemiological Association.
Conflict of interest statement
None declared.
Figures

Similar articles
-
The mediating and moderating effect of BMI in the relationship between air pollution and nonalcoholic fatty liver disease: A prospective cohort study.Environ Pollut. 2025 Sep 15;381:126570. doi: 10.1016/j.envpol.2025.126570. Epub 2025 May 29. Environ Pollut. 2025. PMID: 40449713
-
Air Pollution and Parkinson Disease in a Population-Based Study.JAMA Netw Open. 2024 Sep 3;7(9):e2433602. doi: 10.1001/jamanetworkopen.2024.33602. JAMA Netw Open. 2024. PMID: 39283636 Free PMC article.
-
Association of metabolic signatures of air pollution with MASLD: Observational and Mendelian randomization study.J Hepatol. 2025 Apr;82(4):560-570. doi: 10.1016/j.jhep.2024.09.033. Epub 2024 Sep 28. J Hepatol. 2025. PMID: 39349253
-
Associations of Short-Term and Long-Term Exposure to Ambient Air Pollutants With Hypertension: A Systematic Review and Meta-Analysis.Hypertension. 2016 Jul;68(1):62-70. doi: 10.1161/HYPERTENSIONAHA.116.07218. Epub 2016 May 31. Hypertension. 2016. PMID: 27245182
-
Long-term association of ambient air pollution and hypertension in adults and in children: A systematic review and meta-analysis.Sci Total Environ. 2021 Nov 20;796:148620. doi: 10.1016/j.scitotenv.2021.148620. Epub 2021 Jul 7. Sci Total Environ. 2021. PMID: 34274662
References
-
- Younossi Z, Anstee QM, Marietti M et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 2018;15:11–20. - PubMed
-
- Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011;43:617–49. - PubMed
-
- Riazi K, Azhari H, Charette JH et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2022;7:851–61. - PubMed
-
- Li J, Zou B, Yeo YH et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2019;4:389–98. - PubMed
-
- Sheth SG, Chopra S, Clinical Features and Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease (Nonalcoholic Fatty Liver Disease) in Adults. UpToDate. 2025. https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-met... (28 May 2025, date last accessed).
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical